DSGN Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-08-14SCHEDULE 13G/A0000919574-26-005487SEC →
2026-08-14SCHEDULE 13G0000919574-26-005202SEC →
2026-08-0310-Q0001193125-26-329579SEC →
2026-08-038-K0001193125-26-329570SEC →
2026-06-1140001754129-26-000006SEC →
2026-06-1140001751873-26-000002SEC →
2026-06-1140001579826-26-000002SEC →
2026-06-1140001559570-26-000008SEC →
2026-06-1140001478916-26-000009SEC →
2026-06-1140001193125-26-267732SEC →
2026-06-118-K0001193125-26-267485SEC →
2026-06-09SCHEDULE 13G0000919574-26-003921SEC →
2026-05-188-K0001193125-26-227875SEC →
2026-05-15SCHEDULE 13G/A0000919574-26-003492SEC →
2026-04-2810-Q0001193125-26-187063SEC →
2026-04-288-K0001193125-26-187012SEC →
2026-04-23DEFA14A0001193125-26-173689SEC →
2026-04-23DEF 14A0001193125-26-173678SEC →
2026-04-23ARS0001193125-26-173640SEC →
2026-04-0140001559570-26-000006SEC →
2026-04-0130001559570-26-000004SEC →
2026-04-018-K0001193125-26-137861SEC →
2026-03-11SCHEDULE 13D/A0001072613-26-000257SEC →
2026-03-09S-80001193125-26-098540SEC →
2026-03-0910-K0001193125-26-098491SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
Design Therapeutics (DSGN) — Filings